Skip to main content
Studies address ibrutinib bleeding risk in patients with CLL receiving Mohs surgery
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Studies address ibrutinib bleeding risk in patients with CLL receiving Mohs surgery
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Lymphocytic Leukemia
1
1
Skin Cancer
0
0.96
Mohs Surgery
0
0.99
Surgery
0
0.72
Dermatologic Surgery
0
0.98
Hemorrhage
0
0.97
Anticoagulation Therapy
0
0.18
Thrombocytopenia
0
0.13
Cancer
0
0.12
Squamous Cell Carcinoma
0
0.11
Biologic Therapy
0
0.1
California
0
0.06
Fellowship
0
0.06
Hematology
0
0.06
Platelet Count
0
0.05
Tyrosine Kinase Inhibitor
0
0.04
Antiplatelet Agent
0
0.03
Aspirin
0
0.03
Blood
0
0.03
Leukemia
0
0.03
New York
0
0.03
Tumor
0
0.03
Tyrosine Kinase
0
0.03
Specialty
Lead
score
Dermatology
1
1
Hematology-Oncology
0
0.8
General Surgery
0
0.9
Edit Tags